EXPEDITED REVIEW
Treatment of Calcific Aortic Stenosis With the Percutaneous Heart Valve
Mid-Term Follow-Up From the Initial Feasibility Studies: The French Experience
Alain Cribier, MD, FACC*,*,
Helene Eltchaninoff, MD*,
Christophe Tron, MD*,
Fabrice Bauer, MD*,
Carla Agatiello, MD*,
Deborah Nercolini, MD*,
Sydney Tapiero, MD*,
Pierre-Yves Litzler, MD ,
Jean-Paul Bessou, MD and
Vasilis Babaliaros, MD*
* Department of Cardiology
Department of Cardiac Surgery, Charles Nicolle Hospital, Rouen, France
Manuscript received December 20, 2005;
revised manuscript received January 19, 2006,
accepted January 24, 2006.
* Reprint requests and correspondence: Dr. Alain Cribier, Service de Cardiologie, Hopital Charles Nicolle, 1 rue de Germont, 76 031 Rouen Cedex, France (Email: Alain.Cribier{at}chu-rouen.fr).
OBJECTIVES: The aim of this work was to study the feasibility, safety, efficacy, and durability of percutaneous heart valve (PHV) implantation in the aortic position.
BACKGROUND: We developed a PHV (equine pericardium valve in a balloon-expandable, stainless-steel stent) to treat patients with inoperable aortic stenosis (AS).
METHODS: Thirty-six patients (aortic valve area 0.7 cm2, New York Heart Association [NYHA] functional class IV, and severe comorbidities), formally declined for surgery, were recruited on a compassionate basis. The PHV was implanted by retrograde or antegrade trans-septal approach. Clinical and echocardiographic outcomes were assessed serially.
RESULTS: Twenty-seven patients were implanted successfully (23 antegrade, 4 retrograde) in the subcoronary position with improvement in valve area (0.60 ± 0.11 cm2 to 1.70 ± 0.10 cm2, p < 0.0001) and transvalvular gradient (37 ± 13 mm Hg to 9 ± 2 mm Hg, p < 0.0001). Paravalvular aortic regurgitation was grade 0 to 1 (n = 10), grade 2 (n = 12), and grade 3 (n = 5). One week post-procedure, improvement in left ventricular function (45 ± 18% to 53 ± 14%, p = 0.02) was most pronounced in patients with ejection fraction <50% (35 ± 10% to 50 ± 16%, p < 0.0001). Thirty-day major adverse events after successful implantation were 26% (pericardial tamponade, stroke, arrhythmia, urosepsis, and one death unexplained at autopsy). Eleven patients are currently alive with follow-up of 9 months (n = 2), 10 months (n = 3), 11 months (n = 1), 12 months (n = 2), 23 months (n = 1), and 26 months (n = 2). All patients experienced amelioration of symptoms (>90% NYHA functional class I to II). Percutaneous heart valve function remained unchanged during follow-up, and no deaths were device-related.
CONCLUSIONS: Percutaneous heart valve implantation is feasible in inoperable patients with end-stage AS leading to hemodynamic and clinical improvement. Continued advances and improved patient selection should decrease adverse events in the near future.
This article has been cited by other articles:

|
 |

|
 |
 
I. M. SINGH, E. M. TUZCU, M. H. SHISHEHBOR, S. R. KAPADIA, and R. D. CHRISTOFFERSON
Percutaneous treatment of aortic valve stenosis
Cleveland Clinic Journal of Medicine,
November 1, 2008;
75(11):
805 - 812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Ree, J. B. Bowering, and S. K. W. Schwarz
Case series: Anesthesia for retrograde percutaneous aortic valve replacement - experience with the first 40 patients: [Presentation de cas : L'anesthesie pour un remplacement valvulaire aortique percutane retrograde : notre experience avec les 40 premiers patients]
Can J Anesth,
November 1, 2008;
55(11):
761 - 768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zierer, G. Wimmer-Greinecker, S. Martens, A. Moritz, and M. Doss
The transapical approach for aortic valve implantation.
J. Thorac. Cardiovasc. Surg.,
October 1, 2008;
136(4):
948 - 953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. C. Babaliaros, D. Liff, E. P. Chen, J. H. Rogers, R. A. Brown, V. H. Thourani, R. A. Guyton, S. Lerakis, A. E. Stillman, P. Raggi, et al.
Can Balloon Aortic Valvuloplasty Help Determine Appropriate Transcatheter Aortic Valve Size?
J. Am. Coll. Cardiol. Intv.,
October 1, 2008;
1(5):
580 - 586.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Schofer, M. Schluter, H. Treede, O. W. Franzen, T. Tubler, A. Pascotto, R. I. Low, S. F. Bolling, T. Meinertz, and H. Reichenspurner
Retrograde Transarterial Implantation of a Nonmetallic Aortic Valve Prosthesis in High-Surgical-Risk Patients With Severe Aortic Stenosis: A First-in-Man Feasibility and Safety Study
Circ Cardiovasc Intervent,
October 1, 2008;
1(2):
126 - 133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-Y. Litzler, A. Cribier, A. Zajarias, D. Comte, H. Eltchaninoff, C. Tron, C. Haas-Hubscher, and J.-P. Bessou
Surgical aortic valve replacement after percutaneous aortic valve implantation: What have we learned?
J. Thorac. Cardiovasc. Surg.,
September 1, 2008;
136(3):
697 - 701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Piazza, P. de Jaegere, C. Schultz, A. E. Becker, P. W. Serruys, and R. H. Anderson
Anatomy of the Aortic Valvar Complex and Its Implications for Transcatheter Implantation of the Aortic Valve
Circ Cardiovasc Intervent,
August 1, 2008;
1(1):
74 - 81.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. T.L. Chiam and C. E. Ruiz
Percutaneous Transcatheter Aortic Valve Implantation: Assessing Results, Judging Outcomes, and Planning Trials: The Interventionalist Perspective
J. Am. Coll. Cardiol. Intv.,
August 1, 2008;
1(4):
341 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Vahanian, O. R. Alfieri, N. Al-Attar, M. J. Antunes, J. Bax, B. Cormier, A. Cribier, P. De Jaegere, G. Fournial, A. P. Kappetein, et al.
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Eur. J. Cardiothorac. Surg.,
July 1, 2008;
34(1):
1 - 8.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Walther, V. Falk, J. Kempfert, M. A. Borger, J. Fassl, M. W.A. Chu, G. Schuler, and F. W. Mohr
Transapical minimally invasive aortic valve implantation; the initial 50 patients
Eur. J. Cardiothorac. Surg.,
June 1, 2008;
33(6):
983 - 988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Descoutures, D. Himbert, L. Lepage, B. Iung, D. Detaint, D. Tchetche, E. Brochet, Y. Castier, J.-P. Depoix, P. Nataf, et al.
Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly
Eur. Heart J.,
June 1, 2008;
29(11):
1410 - 1417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Antunes
Percutaneous aortic valve implantation. The demise of classical aortic valve replacement?
Eur. Heart J.,
June 1, 2008;
29(11):
1339 - 1341.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Vahanian, O. Alfieri, N. Al-Attar, M. Antunes, J. Bax, B. Cormier, A. Cribier, P. De Jaegere, G. Fournial, A. P. Kappetein, et al.
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Eur. Heart J.,
June 1, 2008;
29(11):
1463 - 1470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Piazza, Y. Onuma, E. Jesserun, P. P. Kint, A.-M. Maugenest, R. H. Anderson, P. P. T. de Jaegere, and P. W. Serruys
Early and Persistent Intraventricular Conduction Abnormalities and Requirements for Pacemaking After Percutaneous Replacement of the Aortic Valve
J. Am. Coll. Cardiol. Intv.,
June 1, 2008;
1(3):
310 - 316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. F. Tops, D. A. Wood, V. Delgado, J. D. Schuijf, J. R. Mayo, S. Pasupati, F. P.L. Lamers, E. E. van der Wall, M. J. Schalij, J. G. Webb, et al.
Noninvasive Evaluation of the Aortic Root With Multislice Computed Tomography: Implications for Transcatheter Aortic Valve Replacement
J. Am. Coll. Cardiol. Img.,
May 1, 2008;
1(3):
321 - 330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ramaraj and V. L Sorrell
Degenerative aortic stenosis
BMJ,
March 8, 2008;
336(7643):
550 - 555.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Rhodes, Z. M. Hijazi, and R. J. Sommer
Pathophysiology of Congenital Heart Disease in the Adult, Part II: Simple Obstructive Lesions
Circulation,
March 4, 2008;
117(9):
1228 - 1237.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Murtuza, J. R. Pepper, R. DeL Stanbridge, C. Jones, C. Rao, A. Darzi, and T. Athanasiou
Minimal Access Aortic Valve Replacement: Is It Worth It?
Ann. Thorac. Surg.,
March 1, 2008;
85(3):
1121 - 1131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zegdi, G. Sleilaty, A. Lafont, and J.-N. Fabiani
Percutaneous Aortic Valve Replacement With the CoreValve Prosthesis
J. Am. Coll. Cardiol.,
January 15, 2008;
51(2):
170 - 170.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Grossi, C. F. Schwartz, P.-J. Yu, U. P. Jorde, G. A. Crooke, J. B. Grau, G. H. Ribakove, F. G. Baumann, P. Ursumanno, A. T. Culliford, et al.
High-Risk Aortic Valve Replacement: Are the Outcomes as Bad as Predicted?
Ann. Thorac. Surg.,
January 1, 2008;
85(1):
102 - 107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Padera Jr. and F. J. Schoen
Pathology of Cardiac Surgery
Card. Surg. Adult,
January 1, 2008;
3(2008):
111 - 178.
[Full Text]
|
 |
|

|
 |

|
 |
 
N. D. Desai and G. T. Christakis
Bioprosthetic Aortic Valve Replacement: Stented Pericardial and Porcine Valves
Card. Surg. Adult,
January 1, 2008;
3(2008):
857 - 894.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. J. Davidson and D. S. Baim
Percutaneous Aortic Valve Interventions
Card. Surg. Adult,
January 1, 2008;
3(2008):
963 - 971.
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Feldman and M. B. Leon
Prospects for Percutaneous Valve Therapies
Circulation,
December 11, 2007;
116(24):
2866 - 2877.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The Year in Interventional Cardiology
J. Am. Coll. Cardiol.,
July 17, 2007;
50(3):
270 - 285.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Grube, G. Schuler, L. Buellesfeld, U. Gerckens, A. Linke, P. Wenaweser, B. Sauren, F.-W. Mohr, T. Walther, B. Zickmann, et al.
Percutaneous Aortic Valve Replacement for Severe Aortic Stenosis in High-Risk Patients Using the Second- and Current Third-Generation Self-Expanding CoreValve Prosthesis: Device Success and 30-Day Clinical Outcome
J. Am. Coll. Cardiol.,
July 3, 2007;
50(1):
69 - 76.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tabata, Z. Khalpey, S. F. Aranki, G. S. Couper, L. H. Cohn, and P. S. Shekar
Minimal Access Surgery of Ascending and Proximal Arch of the Aorta: A 9-Year Experience
Ann. Thorac. Surg.,
July 1, 2007;
84(1):
67 - 72.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bergler-Klein, G. Mundigler, P. Pibarot, I. G. Burwash, J. G. Dumesnil, C. Blais, C. Fuchs, D. Mohty, R. S. Beanlands, Z. Hachicha, et al.
B-Type Natriuretic Peptide in Low-Flow, Low-Gradient Aortic Stenosis: Relationship to Hemodynamics and Clinical Outcome: Results From the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) Study
Circulation,
June 5, 2007;
115(22):
2848 - 2855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Coats and P. Bonhoeffer
NEW PERCUTANEOUS TREATMENTS FOR VALVE DISEASE
Heart,
May 1, 2007;
93(5):
639 - 644.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, J. Narula, D. J. Sahn, et al.
Highlights of the Year in JACC 2006
J. Am. Coll. Cardiol.,
January 30, 2007;
49(4):
509 - 527.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Authors/Task Force Members, A. Vahanian, H. Baumgartner, J. Bax, E. Butchart, R. Dion, G. Filippatos, F. Flachskampf, R. Hall, B. Iung, et al.
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology
Eur. Heart J.,
January 26, 2007;
(2007)
ehl428v1.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Rahimtoola
The Year in Valvular Heart Disease
J. Am. Coll. Cardiol.,
January 23, 2007;
49(3):
361 - 374.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ye, A. Cheung, S. V. Lichtenstein, S. Pasupati, R. G. Carere, C. R. Thompson, A. Sinhal, and J. G. Webb
Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients
Eur. J. Cardiothorac. Surg.,
January 1, 2007;
31(1):
16 - 21.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Grube, J. C. Laborde, U. Gerckens, T. Felderhoff, B. Sauren, L. Buellesfeld, R. Mueller, M. Menichelli, T. Schmidt, B. Zickmann, et al.
Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study
Circulation,
October 10, 2006;
114(15):
1616 - 1624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Lichtenstein, A. Cheung, J. Ye, C. R. Thompson, R. G. Carere, S. Pasupati, and J. G. Webb
Transapical Transcatheter Aortic Valve Implantation in Humans: Initial Clinical Experience
Circulation,
August 8, 2006;
114(6):
591 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Percutaneous Aortic Valve Implantation: Mid-Term Follow-Up
Journal Watch Cardiology,
May 11, 2006;
2006(511):
2 - 2.
[Full Text]
|
 |
|
|